The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123306304 12330630 4 F 20160809 20160504 20160811 PER PHEH2016US010444 NOVARTIS 0.00 F Y 0.00000 20160811 CN COUNTRY NOT SPECIFIED US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123306304 12330630 1 PS EXTAVIA INTERFERON BETA-1B 1 Subcutaneous WEEKS 1-2: 0.0625 MG (0.25 ML), QOD 125290 .25 ML SOLUTION FOR INJECTION
123306304 12330630 2 SS EXTAVIA INTERFERON BETA-1B 1 Subcutaneous WEEKS 3-4: 0.125 MG (0.5 ML), QOD 125290 .5 ML SOLUTION FOR INJECTION
123306304 12330630 3 SS EXTAVIA INTERFERON BETA-1B 1 Subcutaneous WEEK 5-6: 0.75 ML, (0.1875 MG), QOD 125290 .75 ML SOLUTION FOR INJECTION
123306304 12330630 4 SS EXTAVIA INTERFERON BETA-1B 1 Subcutaneous WEEKS 7+, 1 ML, (0.25 MG), QOD 125290 1 ML SOLUTION FOR INJECTION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123306304 12330630 1 Multiple sclerosis

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
123306304 12330630 Abdominal pain
123306304 12330630 Abdominal pain upper
123306304 12330630 Ankle fracture
123306304 12330630 Asthenia
123306304 12330630 Chills
123306304 12330630 Headache
123306304 12330630 Injection site bruising
123306304 12330630 Injection site mass
123306304 12330630 Injection site pain
123306304 12330630 Ligament sprain
123306304 12330630 Nausea
123306304 12330630 Night sweats
123306304 12330630 Sickle cell anaemia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123306304 12330630 1 20160310 0